Quarterly report pursuant to Section 13 or 15(d)

Revenue Recognition (Details)

v3.19.3
Revenue Recognition (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Total revenues $ 2,927,466 $ 1,807,042 $ 8,006,382 $ 5,076,744
Functional Neurology [Member]        
Total revenues 1,854,251 1,448,850 5,212,460 3,787,712
Biologics and Drug Delivery [Member]        
Total revenues 491,257 190,993 957,673 483,251
Therapy [Member]        
Total revenues 64,095 81,925
Capital Equipment [Member]        
Total revenues 184,825 99,961 700,517 420,039
Product Revenues [Member]        
Total revenues 2,594,428 1,739,804 6,952,575 4,691,002
Capital Equipment and Other [Member]        
Total revenues 210,538 62,238 515,695 218,742
Biologics And Drug Delivery [Member]        
Total revenues 72,500 5,000 335,500 167,000
Therapy [Member]        
Total revenues 50,000 202,612
Service and Other Revenues [Member]        
Total revenues $ 333,038 $ 67,238 $ 1,053,807 $ 385,742